Overview

A Study To See If GSK256073A Can Block Niacin-Induced Flushing In Healthy Volunteers

Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
To test the ability of GSK256073 to block niacin-induced flushing when GSK256073 and niacin are co-administered as single doses to HVTs.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Niacin
Niacinamide
Nicotinic Acids